Kazuyuki Nakagome

14PUBLICATIONS
73CO-AUTHORS
MortalityMedical infection agents (incl. prions)PharmacogenomicsNeurology and neuromuscular diseasesPersonality and individual differences
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 20, 2026
Response to Durability of zuranolone in postpartum depression versus major depressive disorder.

|Feb 19, 2026
Gray and White matter microstructural alterations in major depressive disorder: a multi-center diffusion imaging study.

Kento Takahashi, Taro Suwa, Yujiro Yoshihara

|Nov 18, 2025
Efficacy and safety of zuranolone in Japanese adults with major depressive disorder: A double-blind, randomized, placebo-controlled, Phase 3 clinical trial.

Masaki Kato, Kazuyuki Nakagome, Takamichi Baba

|Jul 23, 2025
Mediators of the Association Between Severity of Noncommunicable Diseases and Subjective Health-Related Quality of Life.

Kazuyuki Nakagome, Michiyo Azechi, Teruo Noguchi

|Jul 15, 2025
Transforming Growth Factor-β Serum Levels Associated with Social Function in Subjects at Ultra-high Risk for Psychosis: A Multicenter Study.

Yuji Yamada, Naoko Kishimoto, Hiromi Tagata

|Apr 14, 2025
Identification of Factors to Predict Transition to Schizophrenia in Subjects with Ultra-high Risk for Psychosis: A Protocol for a Multicenter, Longitudinal Study of Sleep Parameters and Cytokine Levels.

Yuji Yamada, Kazuo Mishima, Takashi Ohnishi

Pageof 3

Frequent Collaborators

4 joint publications

Tomiki Sumiyoshi

3 joint publications

Tomoko Motomiya

3 joint publications

Takeshi Inoue

3 joint publications

Kazuo Mishima